11β-hydroxysteroid dehydrogenases in the brain -: Two enzymes two roles

被引:49
作者
Holmes, MC
Yau, JLW
Kotelevtsev, Y
Mullins, JJ
Seckl, JR
机构
[1] Univ Edinburgh, Mol Med Ctr, Edinburgh EH8 9YL, Midlothian, Scotland
[2] Univ Edinburgh, Coll Med & Vet Sci, Edinburgh EH8 9YL, Midlothian, Scotland
来源
STEROIDS AND THE NERVOUS SYSTEM | 2003年 / 1007卷
关键词
glucocorticoids; 11 beta-hydroxysteroid dehydrogenases; HPA axis; cerebellum; programming;
D O I
10.1196/annals.1286.035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoids affect a wide range of processes in the brain, altering neurotransmission, electrophysiological activity, metabolism, cell division, and death. These actions are mediated by corticosteroid receptors (glucocorticoid and mineralocorticoid) that modify transcriptional activity of target genes. The amount of steroid available to activate these receptors is not only dependent on the circulating levels but also on pre-receptor metabolism of glucocorticoids occurring intracellularly. This metabolism is carried out by the enzymes 11beta-hydroxysteroid dehydrogenases (11beta-HSDs). There are two distinct isozymes, the products of distantly related genes. 11beta-HSD type 2 inactivates glucocorticoids to its inert 11-keto derivative, while 11beta-HSD type 1 elevates intracellular glucocorticoid levels by regenerating active glucocorticoids from circulating 11-dehydrocorticosterone or cortisone. This review highlights the important and very different roles the two enzymes play in the brain, outlining recent results obtained from studying mice with a targeted gene deletion in the 11beta-HSD1 or 11beta-HSD2 genes.
引用
收藏
页码:357 / 366
页数:10
相关论文
共 38 条
[1]   Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice [J].
Alberts, P ;
Engblom, L ;
Edling, N ;
Forsgren, M ;
Klingström, G ;
Larsson, C ;
Rönquist-Nii, Y ;
Öhman, B ;
Abrahmsén, L .
DIABETOLOGIA, 2002, 45 (11) :1528-1532
[2]   Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs.: Discovery of potent and selective inhibitors of the 11β-hydroxysteroid dehydrogenase type 1 [J].
Barf, T ;
Vallgårda, J ;
Emond, R ;
Häggström, C ;
Kurz, G ;
Nygren, A ;
Larwood, V ;
Mosialou, E ;
Axelsson, K ;
Olsson, R ;
Engblom, L ;
Edling, N ;
Rönquist-Nii, Y ;
Öhman, B ;
Alberts, P ;
Abrahmsén, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) :3813-3815
[3]   GRANULE CELL GENESIS IN THE HIPPOCAMPUS OF RATS TREATED NEONATALLY WITH HYDROCORTISONE [J].
BOHN, MC .
NEUROSCIENCE, 1980, 5 (11) :2003-+
[4]   EFFECTS OF NEONATAL HYDROCORTISONE ON RAT CEREBELLAR DEVELOPMENT - AUTORADIOGRAPHIC AND LIGHT-MICROSCOPIC STUDY [J].
BOHN, MC ;
LAUDER, JM .
DEVELOPMENTAL NEUROSCIENCE, 1978, 1 (06) :250-266
[5]   Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2 [J].
Brown, RW ;
Chapman, KE ;
Kotelevtsev, Y ;
Yau, JLW ;
Lindsay, RS ;
Brett, L ;
Leckie, C ;
Murad, P ;
Lyons, V ;
Mullins, JJ ;
Edwards, CRW ;
Seckl, JR .
BIOCHEMICAL JOURNAL, 1996, 313 :1007-1017
[6]   The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. [J].
Brown, RW ;
Diaz, R ;
Robson, AC ;
Kotelevtsev, YV ;
Mullins, JJ ;
Kaufman, MH ;
Seckl, JR .
ENDOCRINOLOGY, 1996, 137 (02) :794-797
[7]  
Diaz R, 1998, J NEUROSCI, V18, P2570
[8]   LOCALIZATION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR [J].
EDWARDS, CRW ;
BURT, D ;
MCINTYRE, MA ;
DEKLOET, ER ;
STEWART, PM ;
BRETT, L ;
SUTANTO, WS ;
MONDER, C .
LANCET, 1988, 2 (8618) :986-989
[9]  
GOMEZSANCHEZ EP, 1992, AM J PHYSIOL, V263, pE1125
[10]   INTRACEREBROVENTRICULAR INFUSION OF ALDOSTERONE INDUCES HYPERTENSION IN RATS [J].
GOMEZSANCHEZ, EP .
ENDOCRINOLOGY, 1986, 118 (02) :819-823